2024-04-08 15:15:00 ET
Summary
- Cancer treatment maker ProfoundBio announced it will be purchased by Denmark’s Genmab for $1.8 billion.
- The deal is the fourth acquisition of a China-related innovative drugmaker by a foreign company in the last four months.
- The deal comes just two months after ProfoundBio announced it raised $112 million in its B-series funding.
The company has become the latest in a recent string of China-related innovative drug makers to be purchased by larger foreign buyers. ...
Read the full article on Seeking Alpha
For further details see:
ProfoundBio Discovers The Joys Of Having A Wealthy Owner